2024 Allied Health Professionals Meeting On-Demand Package
Log in to see your correct pricing, as SGO members receive a discount. All content has been added to the course.
This course includes all CE-eligible sessions recorded at the SGO 2024 Allied Health Professionals Meeting held in Charlotte, North Carolina on September 27-29, 2024. CE is only available for this content through April 7, 2025. After that date registrants of the course will still be able to access the content.
- Opening Session: Rare Tumors - Anil Sood, MD
- ADC’s, Easy as 1,2,3 - Jennifer MacDonald, PharmD, BCOP
- Putting FIGO Staging Updates into Practice - Erin Crane, MD
- Starting a Sexual Health Clinic - Nicole Dreibelbis, WHNP-BC and Nora Lersch, DNP, FNP-BC, AOCNP
- Tumor Board - Whitney Graybill, MD, Jubilee Brown, MD, R. Wendel Naumann, MD
- ERAS and Beyond: Prevention and Management of Post Operative Complications in Gynecologic Oncology - Michelle Davis, MD
- Updates in Clinical Trials - Joshua Cohen, MD
- Management of Immunotherapy Toxicities in GYN Oncology - Kathleen Lutz, NP
- Increasing Knowledge and Support in Survivorship - Jessica Walchonski, PA-C, MMS
- Menopause Management for Gyn Cancer Survivors- Your Complete Menopause Toolkit - Rachel Frankenthal, MMS, PA-C, MPH, MSCP
- Lifestyle Modifications for Cancer Patients - Jenna Unke, PA-C
- Patient Panel - Featuring 3 survivors
- Demystifying Cancer Pain Management - Molly Silver, APRN
- Managing Common Side Effects from Pelvic Radiotherapy - Benjamin Moeller, MD
- Reclaiming Intimacy: How a Cancer Diagnosis Can Impact Sexuality and Intimacy - Nicole Dreibelbis, WHNP-BC
- Pathology of HPV-Associated Neoplasia in the Gynecologic Tract - Levon Katsakhyan, MD
Target Audience
Nurse Practitioners, Physician Assistants/Associates, APPs, NPs, PAs, SGO Members
Learning Objectives
1. Identify rare tumors seen in gynecologic oncology and assess how to treat them.
2. Discuss patient scenarios and compare treatment plans to formulate a recommendation.
3. Review updates in pertinent clinical trials and describe implications for patient care.
Additional Information
| Attachment | Size |
|---|---|
| 287.68 KB | |
| 205.68 KB |
Available Credit
- 13.00 Participation

Facebook
X
LinkedIn
Forward